Related Experiment Video

Updated: May 22, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Epigenetic inactivation of PLCD1 in chronic myeloid leukemia

Jun-Jun Song1, Qiong Liu, Ying Li

  • 1Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.

International Journal of Molecular Medicine
|May 12, 2012
PubMed

Insights

Phospholipase C δ1 (PLCD1) acts as a tumor suppressor in chronic myeloid leukemia (CML). Its promoter methylation inactivates PLCD1, but demethylation restores expression and inhibits CML cell growth.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Phospholipase C δ1 (PLCD1) is a tumor suppressor gene located at the 3p22 locus.
  • PLCD1 regulates energy metabolism, calcium homeostasis, and intracellular movements.
  • PLCD1's tumor suppressor role is established in solid tumors via promoter methylation, but its role in chronic myeloid leukemia (CML) is unknown.

Purpose of the Study:

  • To investigate PLCD1 expression and promoter methylation status in chronic myeloid leukemia (CML).
  • To determine if PLCD1 functions as a tumor suppressor in CML.
  • To explore PLCD1's potential as a biomarker for CML early detection and prognosis.

Main Methods:

  • Semi-quantitative PCR was used to assess PLCD1 expression in CML cell lines and patient samples.
  • Methylation-specific PCR (MSP) analyzed CpG island (CGI) methylation status of the PLCD1 promoter.
  • 5'-aza-2'deoxycytidine was used to induce DNA demethylation and observe PLCD1 expression restoration; functional studies assessed colony formation and cell cycle arrest.

Main Results:

  • PLCD1 expression was reduced in CML K562 cells and patient bone marrow mononuclear cells.
  • PLCD1 promoter CGI methylation was detected in K562 cells and a significant proportion of CML patients, but not in normal controls.
  • Demethylation treatment restored PLCD1 expression, and its ectopic expression inhibited CML cell colony formation and induced G1 arrest.

Conclusions:

  • PLCD1 functions as a tumor suppressor in chronic myeloid leukemia (CML).
  • Promoter methylation inactivates PLCD1 in CML, leading to reduced expression.
  • PLCD1 may serve as a valuable biomarker for CML early detection and prognosis.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...